Loading…
Vilin Bio Med (VILINBIO)₹54.550.00%Pharmaceuticals
At the end of the Jun 2026 quarter, Vilin Bio Med's shareholders were: promoters 56.66%, public 43.34%. Promoter holding is down 2.92 percentage points from 59.58% a quarter earlier. 0.00% of promoter shares were pledged. It had 383 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Promoters | 64.53% | 64.53% | 64.10% | 63.90% | 63.90% | 63.90% | 63.66% | 59.58% | 56.66% |
| Public | 35.47% | 35.47% | 35.90% | 36.10% | 36.10% | 36.10% | 36.34% | 40.42% | 43.34% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 660 | 586 | 582 | 552 | 493 | 477 | 463 | 398 | 383 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Sharaz Shaik | Promoter | 12.03% | +8.66 |
| Shankar Reddy Katireddy | Promoter | 11.66% | 0.00 |
| Pravallika Venna | Promoter | 8.82% | 0.00 |
| Allu Ramakrishna Reddy | Promoter | 7.25% | 0.00 |
| Julakanti Naga Avinash Reddy | Promoter | 5.82% | 0.00 |
| Enspire Institute Of Professional Studies Llp | Public | 4.42% | 0.00 |
| Karunakar Reddy Kundoor | Promoter | 4.34% | +2.99 |
| Amn Ventures Llp | Public | 4.12% | 0.00 |
| Percy Homi Italia | Public | 3.96% | 0.00 |
| Mohan Rao Adhi | Promoter | 3.32% | 0.00 |
| Jwala Veeravenkata Panduranga Praneeth | Promoter | 2.90% | 0.00 |
| Krishna | Public | 2.85% | 0.00 |
| Srinivasa Reddy Devireddy | Public | 1.86% | New |
| Bosco Armando Menezes | Public | 1.07% | New |
| Chenugonipally Maheshwar Reddy | Public | 1.07% | New |
| Glaston Mario Menezes | Public | 1.07% | New |
| Tanmayee Reddy Sama | Promoter | 0.14% | 0.00 |
| Ramiza Shaik | Promoter | 0.13% | 0.00 |
| Anuj Bajpai | Promoter | 0.10% | 0.00 |
| Sneh Bajpai | Promoter | 0.06% | 0.00 |
| Shaik Saraf | Promoter | 0.03% | 0.00 |
| Srinivasa Reddy Devireddy | Promoter | Exited | — |
| Ramesh Reddy Sama | Promoter | Exited | — |
| Sudhanshu Kanda | Public | Exited | — |
Promoters held 56.66% of Vilin Bio Med at the end of the Jun 2026 quarter, down 7.24 percentage points from 63.90% a year earlier.
No. The Jun 2026 filing shows no pledged promoter shares.
Vilin Bio Med had 383 shareholders at the end of the Jun 2026 quarter, against 493 a year earlier.
Enspire Institute Of Professional Studies Llp (Public) held 4.42% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.